Habib Dable

President, Bayer Pharmaceuticals, US

Habib Dable

Habib Dable is President of U.S. Pharmaceuticals, a role he has held since October 2015.

Most recently, Habib was global head of specialty medicine for Bayer HealthCare Pharmaceuticals, a role he held since 2013 and in which was responsible for overseeing four therapeutic areas for the company – hematology, oncology, ophthalmology, and neurology.

Habib began his career at Bayer in 1994 as a sales representative in Canada, where he later and moved on to various sales and marketing roles with increasing management responsibility. He then spent two years at Bayer HealthCare’s office in Osaka, Japan as Head of Strategic Planning, before moving to the United States and serving as Director of International Sales and Marketing. He was later appointed Vice President and Regional Business Unit Head responsible for Latin America, Canada, Asia Pacific and Japan.

From 2008 to 2012, Habib headed Bayer’s global therapeutic area team for Neurology / Ophthalmology, and he was Vice President for Ophthalmology and headed the global launch team for EYLEA® (aflibercept), the company’s treatment for macular degeneration.

Habib earned a Master’s of Business Administration from the University of New Brunswick in Canada, where he also completed his undergraduate study. He is married with two children, and resides in New Jersey. Habib’s personal interests include jogging, squash, golf, youth hockey and the classic English card game, whist.